Cooke Julie sold $558K of NBIX
Cooke Julie (Chief Human Resources Officer) sold 3,520 shares of NEUROCRINE BIOSCIENCES INC (NBIX) at $158.59 ($0.56M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because it is an open-market sale executed under a pre-arranged 10b5-1 plan, it is generally treated as non-informational for valuation, though it can marginally influence sentiment.
Market read
Insider selling disclosure with low informational content; likely minimal impact beyond short-term sentiment.
What to watch
The filing does not specify motives; without additional context (e.g., multiple concurrent sales, changes in option grants), the trading signal is limited.
Background
This is an SEC Form 4 insider transaction disclosure (officer/direct holding) for Neurocrine Biosciences.
Ticker impact
Neurocrine Biosciences disclosed an insider open-market sale by its Chief Human Resources Officer under a pre-arranged 10b5-1 plan.
Low likelihood of sustained price impact; any reaction is likely muted and short-lived.
Form 4 insider sales are common and explicitly tied to a pre-arranged 10b5-1 plan, reducing signal of new, company-specific information.
Market effects
No clear read-across to biotech sector fundamentals from a single officer’s 10b5-1 sale.
None.
None.
Counterpoint
Even with 10b5-1, unusually large or clustered insider selling can coincide with private concerns; traders may still watch for follow-on sales.
Key entities
- issuerNeurocrine Biosciences, Inc.
NBIX, the company whose insider sale was reported on Form 4.
- insiderCooke Julie
Chief Human Resources Officer who sold 3,520 shares for ~$558.2K.
